Interview with Dr. Matthew Johnson, a behavioral pharmacologist at Johns Hopkins University, who is impressed by the research in the three big categories -- psilocybin and LSD for cancer-related anxiety and depression, psilocybin for addiction and MDMA for PTSD.
-
Ron Shore, a Research Scientist at Queen’s University, concludes in this article that there is a pressing need for Canadian veterans to have timely and equitable access to psychedelic assisted therapy.
